The Lyme Broad Coverage Antibody (BCA) Assay is a qualitative test designed to detect IgM and IgG antibodies to Lyme Borreliae group-specific antigens in human serum. The sensitivity of the Lyme BCA Assay is 90%, and the specificity is 97%.

Principle: The test detects IgM and IgG antibodies to the Lyme Borreliae group, and should be used in conjunction with patient clinical symptoms and history.

Stage of Disease: Any Stage of Disease

Test Methodology: ImmunoBlot